DCTN4 Antibody (N-term) Blocking peptide
€363.00
In stock
SKU
AC-BP13454a
Background:
DCTN4 could have a dual role in dynein targeting and in ACTR1A/Arp1 subunit of dynactin pointed-end capping. Could be involved in ACTR1A pointed-end binding and in additional roles in linking dynein and dynactin to the cortical cytoskeleton.
Other Names:
Dynactin subunit 4, Dyn4, Dynactin subunit p62, DCTN4
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13454a was selected from the N-term region of DCTN4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: DCTN4 (HGNC:15518)
Gene ID: 51164
Primary Accession: Q9UJW0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
DCTN4 could have a dual role in dynein targeting and in ACTR1A/Arp1 subunit of dynactin pointed-end capping. Could be involved in ACTR1A pointed-end binding and in additional roles in linking dynein and dynactin to the cortical cytoskeleton.
Other Names:
Dynactin subunit 4, Dyn4, Dynactin subunit p62, DCTN4
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13454a was selected from the N-term region of DCTN4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: DCTN4 (HGNC:15518)
Gene ID: 51164
Primary Accession: Q9UJW0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review